These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29750425)

  • 1. Increased infiltration of macrophages to radioresistant lung cancer cells contributes to the development of the additional resistance of tumor cells to the cytotoxic effects of NK cells.
    Shen M; Chen Y; Xu L; Zhu R; Xue X; Tsai Y; Keng PC; Lee SO; Chen Y
    Int J Oncol; 2018 Jul; 53(1):317-328. PubMed ID: 29750425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro-induced M2 type macrophages induces the resistance of prostate cancer cells to cytotoxic action of NK cells.
    Xu L; Shen M; Chen X; Yang DR; Tsai Y; Keng PC; Lee SO; Chen Y
    Exp Cell Res; 2018 Mar; 364(1):113-123. PubMed ID: 29408565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocytes affect castration-resistant prostate cancer cells to develop the resistance to cytotoxic action of NK cells with alterations of PD-L1/NKG2D ligand levels in tumor cells.
    Xu L; Shen M; Chen X; Zhu R; Yang DR; Tsai Y; Keng PC; Chen Y; Lee SO
    Prostate; 2018 Apr; 78(5):353-364. PubMed ID: 29330929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathway.
    Shen MJ; Xu LJ; Yang L; Tsai Y; Keng PC; Chen Y; Lee SO; Chen Y
    Oncotarget; 2017 Oct; 8(46):80506-80520. PubMed ID: 29113321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.
    Xu L; Chen X; Shen M; Yang DR; Fang L; Weng G; Tsai Y; Keng PC; Chen Y; Lee SO
    Mol Oncol; 2018 Mar; 12(3):269-286. PubMed ID: 28865178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition.
    Yang L; Shen M; Xu LJ; Yang X; Tsai Y; Keng PC; Chen Y; Lee SO
    Sci Rep; 2017 Aug; 7(1):7958. PubMed ID: 28801607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FASN-TGF-β1-PD-L1 axis contributes to the development of resistance to NK cell cytotoxicity of cisplatin-resistant lung cancer cells.
    Shen M; Tsai Y; Zhu R; Keng PC; Chen Y; Chen Y; Lee SO
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Mar; 1863(3):313-322. PubMed ID: 29306075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases.
    Dhupkar P; Gordon N; Stewart J; Kleinerman ES
    Cancer Med; 2018 Jun; 7(6):2654-2664. PubMed ID: 29733528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway.
    Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F
    Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma.
    Zhang Y; Du W; Chen Z; Xiang C
    Exp Cell Res; 2017 Oct; 359(2):449-457. PubMed ID: 28830685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of platinum‑based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death‑1 ligand 1 and HLA class I in non‑small cell lung cancer.
    Okita R; Maeda A; Shimizu K; Nojima Y; Saisho S; Nakata M
    Oncol Rep; 2019 Aug; 42(2):839-848. PubMed ID: 31173242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells.
    Schilling D; Kühnel A; Tetzlaff F; Konrad S; Multhoff G
    Cancer Immunol Immunother; 2015 May; 64(5):599-608. PubMed ID: 25854583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to cigarette smoke suppresses IL-15 generation and its regulatory NK cell functions in poly I:C-augmented human PBMCs.
    Mian MF; Pek EA; Mossman KL; Stämpfli MR; Ashkar AA
    Mol Immunol; 2009 Sep; 46(15):3108-16. PubMed ID: 19592095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.
    Boerman GH; van Ostaijen-ten Dam MM; Kraal KC; Santos SJ; Ball LM; Lankester AC; Schilham MW; Egeler RM; van Tol MJ
    Cancer Immunol Immunother; 2015 May; 64(5):573-83. PubMed ID: 25854581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands.
    Schulz U; Kreutz M; Multhoff G; Stoelcker B; Köhler M; Andreesen R; Holler E
    Scand J Immunol; 2010 Oct; 72(4):319-31. PubMed ID: 20883317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation.
    Tietje A; Li J; Yu X; Wei Y
    Gene Ther; 2014 May; 21(5):468-75. PubMed ID: 24572784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of murine susceptibility to tumor, parasite and bacterial challenge with altered cell-mediated immunity following systemic exposure to the tumor promoter phorbol myristate acetate.
    Murray MJ; Lauer LD; Luster MI; Luebke RW; Adams DO; Dean JH
    Int J Immunopharmacol; 1985; 7(4):491-500. PubMed ID: 3876295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy.
    Park MJ; Bae JH; Chung JS; Kim SH; Kang CD
    Immunol Invest; 2011; 40(4):367-82. PubMed ID: 21314289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells.
    Yin T; Wang G; He S; Liu Q; Sun J; Wang Y
    Cell Immunol; 2016 Feb; 300():41-5. PubMed ID: 26677760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.